Sufjan Stevens is battling Guillain-Barré syndrome, a devastating autoimmune disease that has left him wheelchair-bound and required him to relearn how to walk. Stevens, 48, shared his scary medical ...

Sufjan Stevens is not known to over-share on social media, but he has posted a troubling update to Instagram to announce that he was recently diagnosed with Guillain-Barré Syndrome, a rare auto immune ...

Popular indie folk singer Sufjan Stevens revealed that he was in the process of learning how to re-walk again after being diagnosed with an autoimmune disease, Guillain-Barre Syndrome (GBS). Stevens, ...

In the fall of 2022, Dr. William Dugal, then 32, contracted COVID-19 and began experiencing unusual symptoms. “It started with the numbness in my feet, almost like my shoes were too tight, and it ...

Guillain-Barre syndrome following a virus can damage nerves. Intense physical therapy needed to rebuild connections.

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) ...

Jenna Jameson was misdiagnosed with Guillain-Barré syndrome (GBS) following days of hospital treatment, her partner has revealed. Erstwhile adult film star Jameson, 47, had shared in a January 10 ...

Guillain-Barre syndrome refers to the condition where the immune system of the body starts attacking the peripheral nerves. Usually, this condition is triggered by an acute bacterial or viral ...

BROOKLINE (CBS) – Before heading off to college and beginning his adult life, George Flint of Brookline will run the Boston Marathon Monday - a bittersweet 'so long' to his city. "It feels like one ...

Sufjan Stevens is battling Guillain-Barré Syndrome, he revealed in a post on his website. The diagnosis is the reason he hasn’t done any interviews in support of his upcoming album, Javelin, which is ...

A rare case highlights Guillain-Barré syndrome as the first sign of Hodgkin’s lymphoma, emphasizing the need to consider malignancy in unexplained or refractory neuropathies.